EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Brown & Brown, Inc.
EL7 Factor Analysis
How we score this
Overall51
Balanced — near the middle of the marketFalling StarF 4/9Better than 51% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
47
21.1x▼17.8xAround median
▸
Growth
74
34.2%▲7.1%Top tier
▸
Quality
59
——Around median
▸
Safety
54
——Around median
▸
Capital Return
44
0.97%▼2.12%Around median
▸
Momentum
29
-24.6%▼2.9%Bottom tier
▸
Sentiment
77
12▲3Top tier
BRO

BRO Brown & Brown, Inc.

Brown & Brown, Inc. · NYSE
Market Closed
66.19
▼ ⁦-0.21%⁩ (-0.14)
Market Cap$22.1B
Beta0.58
52w Low52w High
53.8196.55
Last Week
⁦-8.13%⁩
Last Month
⁦-7.56%⁩
Last 3 Months
⁦+11.98%⁩
Last Year
⁦-30.58%⁩
Fair Value
Current price$66
Analyst target · 6 analysts
$73
⁦+10%⁩
See it undervalued
Range ⁦$55–$90⁩
vs
DCF (estimate)
$60
⁦-9%⁩
Sees it slightly overvalued
⁦7.9⁩% discount · ⁦3⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$60–$73⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 6 analysts setting price target
$72.50
⁦+9.5%⁩
Current Price $66.19·Median $72.50
Low
$55.00
High
$90.00
Current price
$66.19
Average target
$72.50
Street summary

Stable Target Amid Divergent Valuations

The average price target has remained unchanged at 72.5 over the last 30 days, despite the number of analysts included decreasing from 7 to 6 in the latest comparison. The current range is between 55 and 90, reflecting a clear divergence in estimates; consensus is approximately 9.5% above the current price of 66.19, while the lower bound indicates downside risk and the upper bound points to greater upside potential.

As of 2026-09-11
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 3.26
Hold
Analyst coverage
19
Buy conviction
21%
Rating activity · 30d
0↑ · 0↓
Target dispersion
53%
Wide
Analyst ratings over time19 analysts rating
2
2
14
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.29 → 3.26
Recent analyst moves
  • = Reiterate2026-08-19
    Morgan Stanley
    Underweight
  • = Reiterate2026-07-29
    Jefferies
    Hold
  • = Reiterate2026-07-29
    RBC Capital
    Sector Perform
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    21.15x
    3.16x25.26x
    Near median
  • Forward P/E
    14.24x
    2.76x22.06x
    Above average
  • EV / EBITDA
    —
    —
  • FCF Yield
    —
    —
  • Revenue Growth YoY
    34.2%
    -36.3%104.2%
    Above average
  • EPS Growth YoY
    -10.3%
    -99.4%194.2%
    Near median
  • Gross Margin
    —
    —
  • ROIC
    —
    —
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    1.0%
    0.6%9.0%
    Low
  • Payout Ratio
    18.2%
    9.8%97.8%
    Low
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-28 data

Company Overview

Brown & Brown provides risk management solutions through two segments, Retail and Specialty Distribution, with its business focused on serving clients through risk advisors, brokers, insurance programs, and delegated underwriting. The company generates revenue from commissions associated with placing insurance policies, contingent commissions and profit-sharing, as well as program and wholesale distribution operations; strong underwriting profitability and lower storm claims supported contingent commissions in Specialty Distribution during Q2 FY2026.

In Q2 FY2026, revenue reached $1.7 billion, representing total growth of 30.4%, with Accession contributing approximately $410 million, or about 24% of quarterly revenue. Net income according to EDGAR filings was approximately $288 million, and earnings per share were $0.84, equivalent to a net income margin of about 16.9%, while adjusted earnings per share were $1.07 and grew 3.9%. The adjusted EBITDAC margin decreased by 100 basis points to 35.7%, despite EBITDAC growth of 27% and a 17.4% increase in pre-tax income.

Revenue for the twelve-month period of FY2026 was approximately $6.8 billion, net income was $1.2 billion, and earnings per share were approximately $3.61. In Q2 FY2026, Retail segment revenue grew 35.9% and achieved organic growth of 2.5% including contingent commissions and 1.5% excluding them, while Specialty Distribution revenue grew 28.1%, but its organic growth was negative 1.6% including contingent commissions and negative 3.5% excluding them.

What's Driving the Stock

  • Accession added approximately $410 million to Q2 FY2026 revenue, with its margins remaining in line with management’s expectations, and the company reaffirmed its target of achieving integration savings of between $30 million and $40 million during FY2026.
  • Management expects organic growth to improve in the second half of FY2026 to a range of 1.5%–2.5% for Retail and a range of 2%–4% for Specialty Distribution, both excluding contingent commissions. It also expects to recognize most of the approximately $10 million in deferred new-business revenue in Q3 FY2026.
  • Brown & Brown entered into partnerships with Anthropic, McKinsey, and Accenture to develop artificial intelligence applications in sales, coverage placement, submissions, underwriting, and support functions. Management does not expect additional technology spending at the current stage, as it is redirecting existing resources, and over the coming quarters and years it is targeting faster execution cycles, higher productivity, stronger organic growth, and better margins.
  • The company generated approximately $610 million in operating cash flow in the first half of FY2026, an increase of $70 million, or 13%, and management expects a long-term cash conversion rate of between 24% and 27%. This provides flexibility to balance capital allocation among share repurchases, debt reduction, talent recruitment, technology investment, and selective acquisitions.
  • Employee benefits consulting remains a source of demand amid medical cost increases of 8%–10% and pharmaceutical cost increases of more than 10%. Meanwhile, the company is building growth opportunities in Europe by recruiting new specialists within its wholesale distribution and program operations in London.

Buying & Selling Case

▲ Buying Case4 pts

  • +Total revenue increased 30.4% in Q2 FY2026, with Accession contributing approximately $410 million, while management maintained its annual integration savings target of $30–40 million.
  • +Liquidity supports capital allocation flexibility; operating cash flow in the first half of FY2026 increased 13% to $610 million, and the company repurchased approximately 9 million shares during the nine months preceding the call.
  • +The Retail segment showed signs of improvement, with organic growth reaching 2.5% including contingent commissions, while net new business exceeded management’s expectations due to the unified sales model and team collaboration.
  • +The artificial intelligence strategy supported by partnerships with Anthropic, McKinsey, and Accenture could improve sales, underwriting, and service efficiency without additional technology spending announced for FY2026, with management confirming that it is targeting organic growth and margin expansion over time.

▼ Selling Case6 pts

Valuation

Analyst consensus on BRO stock is “Neutral,” with an average target of $72.5, within a wide range of $55 to $90. The average target is below the 52-week range high of $97.49, while the highest target approaches that high and the lowest target is slightly above the range low of $53.81, reflecting clear divergence over the impact of Accession integration versus weak organic growth and catastrophe-exposed property insurance pricing pressures.

HoldAnalyst target: $72.5(+9.5%)

Figures in the text are as of 2026-08-28; the live price is shown at the top of the page.

FAQ

How did Brown & Brown perform in Q2 FY2026?

Revenue reached $1.7 billion and grew 30.4% compared with Q2 FY2025. Net income according to EDGAR filings was approximately $288 million, and earnings per share were $0.84, while adjusted earnings per share were $1.07 and grew 3.9%. Adjusted EBITDAC grew 27%, but its margin decreased by 100 basis points to 35.7%.

What was Accession’s impact on BRO’s results?

Accession contributed approximately $410 million to Q2 FY2026 revenue, and its margins were in line with management’s expectations. The company indicated that the business operates at an overall margin of approximately 35% and that its annual revenue is still expected to fall within the range previously specified by management. Brown & Brown also reaffirmed its target of between $30 million and $40 million in integration savings during FY2026.

Why was organic growth weak despite the increase in total revenue?

Consolidated organic growth declined 0.7% excluding contingent commissions in Q2 FY2026, despite total revenue growth of 30.4% supported by acquisitions. Specialty Distribution recorded negative organic growth of 3.5% excluding contingent commissions and was affected by approximately 200 basis points due to the deferral of roughly $10 million in new-business revenue. A 15%–35% decline in catastrophe-exposed property insurance pricing also pressured premium-linked revenue.

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

−
Growth faces direct pressure from a 15%–35% decline in catastrophe-exposed property insurance pricing due to insurance capital supply exceeding demand, and management expects the pressure to continue in the second half of FY2026. This was particularly evident in Specialty Distribution, which recorded negative organic growth of 3.5% excluding contingent commissions in Q2 FY2026.
  • −The company expects a negative impact of between $50 million and $60 million on FY2026 revenue due to new and lost business and incentives associated with employees leaving for an emerging broker. Although Brown & Brown has begun refilling most positions, management said it had not replaced all departing employees as of July 28, 2026.
  • −Consolidated organic growth in Q2 FY2026 declined 0.7% excluding contingent commissions, while it reached only 0.7% when including them. Management also acknowledged that Retail organic growth, despite improving to 1.5% excluding contingent commissions, had not yet reached its target level.
  • −The consolidated adjusted EBITDAC margin decreased by 100 basis points to 35.7%, and the Specialty Distribution margin fell by 400 basis points to 42.7% due to lower unit growth and investment in European capabilities. The Retail margin benefited from nonrecurring accrual adjustments of approximately 110 basis points, and management confirmed that these benefits would not recur in Q3 and Q4 FY2026.
  • −Competition in the excess and specialty insurance market is intensifying from admitted insurers and competing programs, alongside strong competition for talent following the expansion of work across multiple locations. Management confirmed that this environment will continue to pressure the program business, even as it maintains underwriting discipline.
  • −The artificial intelligence initiatives involve unresolved execution and cost risks; management said the industry does not yet fully understand token costs or usage patterns, and that higher spending may depend on the speed of change implementation and employee training. The company does not expect additional spending at the current stage, but it committed to disclosing it if circumstances change and affect margins.
  • What is Brown & Brown’s outlook for the second half of FY2026?

    Management expects organic growth excluding contingent commissions of between 1.5% and 2.5% in Retail and between 2% and 4% in Specialty Distribution. It also expects to recognize most of the approximately $10 million in deferred new-business revenue in Q3 FY2026. Regarding margins, the company maintained its expectation for the FY2026 margin to remain approximately stable excluding the impact of lower investment income, with integration savings of between $30 million and $40 million.

    How does Brown & Brown plan to use artificial intelligence?

    The company formed partnerships with Anthropic, McKinsey, and Accenture to develop artificial intelligence applications in sales, coverage placement, submissions, underwriting, and support functions. The initiative aims to shorten work cycles, increase productivity, and improve client outcomes, and management does not believe the technology will eliminate the need for risk advisors, brokers, or delegated underwriters. As of the July 28, 2026 call, the company had not announced additional technology spending because it is redirecting existing resources toward data, analytics, innovation, and artificial intelligence.

    What are the main operational risks facing BRO stock?

    Catastrophe-exposed property pricing is declining 15%–35%, while admitted insurance markets and programs have become more competitive within the excess and specialty insurance market. The company expects an impact of between $50 million and $60 million on FY2026 revenue associated with employee departures and the resulting effect on business and incentives. The Specialty Distribution margin also decreased by 400 basis points to 42.7%, and the approximately 110-basis-point benefit from accrual adjustments that supported the Retail margin in Q2 FY2026 will not recur.